Penumbra Inc
NYSE:PEN
Penumbra Inc
Cash from Financing Activities
Penumbra Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Penumbra Inc
NYSE:PEN
|
Cash from Financing Activities
$16.2m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Penumbra Inc's Cash from Financing Activities?
Cash from Financing Activities
16.2m
USD
Based on the financial report for Dec 31, 2023, Penumbra Inc's Cash from Financing Activities amounts to 16.2m USD.
What is Penumbra Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-51%
Over the last year, the Cash from Financing Activities growth was 39%. The average annual Cash from Financing Activities growth rates for Penumbra Inc have been -51% over the past three years .